Copyright
©The Author(s) 2015.
World J Gastroenterol. Oct 28, 2015; 21(40): 11469-11480
Published online Oct 28, 2015. doi: 10.3748/wjg.v21.i40.11469
Published online Oct 28, 2015. doi: 10.3748/wjg.v21.i40.11469
Ref. | Number of participants | Population | Endoscopic index used | Endoscopic indexcut off | Faecal lactoferrincut off (μg/mL) | Outcome measures | Correlation | |||||
CD | UC | Sensitivity | Specificity | PPV | NPV | r value | P value | |||||
Crohn’s disease studies | ||||||||||||
Sipponen et al[17] | 19 | Adults | SES-CD | ≤ 2 | < 7.25 | - | 80% | - | - | - | - | |
Pfefferkorn et al[38] | 54 | Paediatrics | Unique score | ≥ 7.25 | 100% | 43% | 70% | 100% | - | < 0.001 | ||
≥ 60 | 84% | 74% | 81% | 77% | ||||||||
Sipponen et al[18] | 61 | Adults | SES-CD (total) | ≤ 3 | < 7.25 | - | - | - | - | 0.705% | < 0.001 | |
SES-CD (colon) | ≤ 3 | < 7.25 | - | - | - | - | 0.627% | < 0.001 | ||||
SES-CD (ileal) | ≤ 3 | < 7.25 | - | - | - | - | 0.18% | > 0.05 | ||||
Sipponen et al[19] | 15 | Adults | CDEIS | ≤ 2 | < 10 | 77% | 100% | 100% | 58% | 0.865% | < 0.001 | |
Sipponen et al[20] | 77 | Adults | CDEIS | ≤ 2 | < 10 | 66% | 92% | 94% | 59% | 0.773% | < 0.001 | |
< 7.25 | 71% | 83% | 89% | 60% | ||||||||
Jones et al[24] | 164 | Adults | SES-CD | ≤ 6 | < 7.25 | - | - | - | - | 0.48% | < 0.05 | |
Langhorst et al[23] | 43 | Adults | SES-CD | > 7.25 | 81.8% | 60% | 87.1% | 50% | 0.42% | < 0.01 | ||
> 7.05 | 81.8% | 60% | 87.1% | 50% | ||||||||
Schoepfer et al[22] | 36 | Adults | SES-CD | ≤ 19 | 7 | - | - | - | - | - | < 0.0001 | |
Schoepfer et al[26] | 24 | Adults | SES-CD | ≤ 19 | < 7 | - | - | - | - | - | 0.0008 | |
D'Incà et al[28] | 31 | Adults | SES-CD | - | - | - | - | 0.192% | 0.545 | |||
Mixed inflammatory bowel disease population studies | ||||||||||||
Vieira et al[30] | 38 | 40 | Adults | CDEIS; Mayo | ≤ 2; ≤ 2 | 4-8 | 93.2% | 76.5% | 83.7% | 89.7% | - | 0 |
Schoepfer et al[22] | 36 | 28 | Adults | SES-CD; Rachmilewitz | ≤ 19; ≤ 4 | 7 | - | - | - | - | - | < 0.0001 |
Silberer et al[32] | 21 | 18 | Adults | Stange | 6.64 | 33.3% | 95% | - | - | - | 0.0059 | |
Ulcerative colitis studies | ||||||||||||
Langhorst et al[23] | 42 | Adults | Mayo | > 7.25 | 88.9% | 66.7% | 82.8% | 76.9% | 0.56% | < 0.001 | ||
> 7.05 | 92.6% | 66.7% | 83.3% | 83.3% | ||||||||
Schoepfer et al[22] | 28 | Adults | Rachmilewitz | ≤ 4 | 7 | - | - | - | - | - | 0.078 | |
Schoepfer et al[26] | 12 | Adults | Rachmilewitz | ≤ grade 1 | < 7 | - | - | - | - | - | 0.7815 | |
D'Incà et al[28] | 46 | Adults | Mayo | - | - | - | - | 0.354% | 0.023 |
- Citation: Boon GJ, Day AS, Mulder CJ, Gearry RB. Are faecal markers good indicators of mucosal healing in inflammatory bowel disease? World J Gastroenterol 2015; 21(40): 11469-11480
- URL: https://www.wjgnet.com/1007-9327/full/v21/i40/11469.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i40.11469